X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nonrelapse mortality (107) 107
index medicus (88) 88
transplantation (81) 81
humans (79) 79
hematology (75) 75
female (64) 64
male (63) 63
adult (61) 61
immunology (60) 60
middle aged (59) 59
hematopoietic stem cells (49) 49
adolescent (43) 43
mortality (42) 42
stem cells (42) 42
versus-host-disease (41) 41
aged (37) 37
hematology, oncology and palliative medicine (35) 35
retrospective studies (35) 35
transplantation, homologous (33) 33
young adult (33) 33
bone-marrow-transplantation (32) 32
prognosis (28) 28
hematopoietic stem cell transplantation (27) 27
analysis (26) 26
survival (25) 25
oncology (24) 24
survival analysis (24) 24
transplantation conditioning - methods (24) 24
acute myeloid-leukemia (23) 23
health aspects (22) 22
hematopoietic stem cell transplantation - adverse effects (21) 21
risk factors (21) 21
hematologic neoplasms - therapy (20) 20
hematopoietic stem cell transplantation - methods (20) 20
treatment outcome (19) 19
leukemia (18) 18
acute disease (17) 17
child (17) 17
hematopoietic stem cell transplantation - mortality (17) 17
risk (17) 17
graft vs host disease - mortality (16) 16
hematologic neoplasms - mortality (15) 15
recipients (15) 15
survival rate (15) 15
bone marrow (14) 14
c-reactive protein (14) 14
child, preschool (14) 14
graft vs host disease - etiology (14) 14
medical research (14) 14
medicine, experimental (14) 14
stem-cell transplantation (14) 14
allogeneic stem cell transplantation (13) 13
patient outcomes (13) 13
relapse (13) 13
disease-free survival (12) 12
graft-versus-host disease (12) 12
allografts (11) 11
article (11) 11
bone-marrow (11) 11
cancer (11) 11
care and treatment (11) 11
comorbidity (11) 11
recurrence (11) 11
transplantation conditioning (11) 11
chemotherapy (10) 10
graft vs host disease - diagnosis (10) 10
infant (10) 10
iron overload (10) 10
leukemia, myeloid, acute - therapy (10) 10
medical colleges (10) 10
overall survival (10) 10
unrelated donors (10) 10
abridged index medicus (9) 9
allogeneic hematopoietic stem cell transplantation (9) 9
ferritin (9) 9
graft vs host disease - immunology (9) 9
hematopoietic-cell transplantation (9) 9
outcomes (9) 9
prognostic impact (9) 9
proportional hazards models (9) 9
allogeneic hematopoietic cell transplantation (8) 8
blood (8) 8
chronic disease (8) 8
engraftment (8) 8
ferritins - blood (8) 8
graft vs host disease - pathology (8) 8
gvhd (8) 8
hematologic malignancies (8) 8
myeloablative agonists - therapeutic use (8) 8
research (8) 8
transplantation conditioning - mortality (8) 8
transplantation, homologous - methods (8) 8
acute gvhd (7) 7
adults (7) 7
biomarkers (7) 7
children (7) 7
comorbidity index (7) 7
complications (7) 7
disease (7) 7
hematologic neoplasms - blood (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 10/2017, Volume 23, Issue 10, pp. 1646 - 1650
Journal Article
Cancer, ISSN 0008-543X, 05/2008, Volume 112, Issue 9, pp. 1992 - 2001
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 2008 - 2016
Abstract Cytomegalovirus (CMV) infection is a major infectious complication after allogeneic hematopoietic cell transplantation (allo-HSCT). Recently, it was... 
Hematology, Oncology and Palliative Medicine | Cytomegalovirus | Risk of relapse | Allogeneic hematopoietic stem cell transplantation | Nonrelapse mortality | DONOR | BONE-MARROW | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | SEROSTATUS | TRANSPLANTATION | cell transplantation | IMPACT | CMV REACTIVATION | DOUBLE-BLIND | INFECTION | RETROSPECTIVE ANALYSIS | HEMATOLOGY | Allogeneic hematopoietic stem | Graft vs Host Disease - therapy | Myeloablative Agonists - therapeutic use | Recurrence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Cytomegalovirus Infections - immunology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Transplantation, Homologous | Cytomegalovirus Infections - mortality | Myelodysplastic Syndromes - therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Societies, Medical | Graft vs Host Disease - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Cytomegalovirus Infections - virology | Adult | Female | Unrelated Donors | Retrospective Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | Japan | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Cytomegalovirus - immunology | Adolescent | Myelodysplastic Syndromes - mortality | Cytomegalovirus Infections - therapy | Aged | Transplantation Conditioning | Myelodysplastic Syndromes - pathology | Virus Activation - immunology | Myelodysplastic Syndromes - immunology | Care and treatment | Relapse | Stem cells | Cytomegalovirus infections | Transplantation | Health aspects | Risk factors | Hematopoietic stem cells | Diseases
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2009, Volume 15, Issue 2, pp. 195 - 204
Journal Article
Journal Article
by Arai, Sally and Arora, Mukta and Wang, Tao and Spellman, Stephen R and He, Wensheng and Couriel, Daniel R and Urbano-Ispizua, Alvaro and Cutler, Corey S and Bacigalupo, Andrea A and Battiwalla, Minoo and Flowers, Mary E and Juckett, Mark B and Lee, Stephanie J and Loren, Alison W and Klumpp, Thomas R and Prockup, Susan E and Ringdén, Olle T.H and Savani, Bipin N and Socié, Gérard and Schultz, Kirk R and Spitzer, Thomas and Teshima, Takanori and Bredeson, Christopher N and Jacobsohn, David A and Hayashi, Robert J and Drobyski, William R and Frangoul, Haydar A and Akpek, Görgün and Ho, Vincent T and Lewis, Victor A and Gale, Robert Peter and Koreth, John and Chao, Nelson J and Aljurf, Mahmoud D and Cooper, Brenda W and Laughlin, Mary J and Hsu, Jack W and Hematti, Peiman and Verdonck, Leo F and Solh, Melhelm M and Norkin, Maxim and Reddy, Vijay and Martino, Rodrigo and Gadalla, Shahinaz and Goldberg, Jenna D and McCarthy, Philip L and Pérez-Simón, José A and Khera, Nandita and Lewis, Ian D and Atsuta, Yoshiko and Olsson, Richard F and Saber, Wael and Waller, Edmund K and Blaise, Didier and Pidala, Joseph A and Martin, Paul J and Satwani, Prakash and Bornhäuser, Martin and Inamoto, Yoshihiro and Weisdorf, Daniel J and Horowitz, Mary M and Pavletic, Steven Z and Graft-Vs-Host Dis Working Comm CIB and Graft-vs-Host Disease Working Committee of the CIBMTR and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning i Sörmland (CKFD)
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 2, pp. 266 - 274
Abstract Although transplant practices have changed over the last decades, no information is available on trends in incidence and outcome of chronic... 
Hematology, Oncology and Palliative Medicine | cGVHD | Allogeneic transplant | Nonrelapse mortality | Incidence | HEMATOPOIETIC-CELL TRANSPLANTATION | BONE-MARROW | UNRELATED DONORS | COMPETING RISKS | SINGLE-CENTER | IMMUNOLOGY | CONSENSUS DEVELOPMENT PROJECT | TRANSPLANTATION | REDUCED-INTENSITY | WORKING GROUP-REPORT | CLINICAL-TRIALS | STEM-CELL | HEMATOLOGY | Myeloablative Agonists - therapeutic use | Humans | Middle Aged | Child, Preschool | Infant | Male | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Transplantation, Homologous | Myelodysplastic Syndromes - therapy | Graft vs Host Disease - mortality | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Odds Ratio | Child | Graft vs Host Disease - etiology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Infant, Newborn | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | International Cooperation | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Adolescent | Myelodysplastic Syndromes - mortality | Survival Analysis | Bone Marrow Transplantation - adverse effects | Myelodysplastic Syndromes - pathology | Chronic Disease | Medicine, Experimental | Bone marrow | Medical research | Reports | Transplantation | Analysis
Journal Article
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 02/2015, Volume 21, Issue 2, pp. 266 - 274
Although transplant practices have changed over the last decades, no information is available on trends in incidence and outcome of chronic graft-versus-host... 
Allogeneic transplant | Nonrelapse mortality | CGVHD | Incidence
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2008, Volume 14, Issue 9, pp. 985 - 992
Journal Article